free性video西欧极品,伊人依成久久人综合网,中文字幕人妻一区二区三区熟女,男女高潮激烈无遮挡免费观软件 ,成人3d动漫一区二区三区

  • Symic Bio Announces Results from SB-030 Trial americanpharmaceuticacreview
    November 03, 2017
    Symic Bio announced results from the Phase 1/2 SHIELD trial evaluating SB-030, a locally administered therapeutic, in patients with peripheral vascular disease undergoing angioplasty.
PharmaSources Customer Service